• Minutes of a meeting of the Federal Interagency Advisory Committee 
on Recombinant DNA Research, July 17, 1979. 
0 Federal Registers of July 31 and August 3, 1979, announcing actions 
to be considered at a meeting of the RAC, September 6-7, 1979. 
0 Minutes of that meeting. 
0 Federal Register of November 30, 1979, containing proposed revised 
guidelines issued for public comment, followed by a combined Deci- 
sion document and Environmental Impact Assessment. 
0 Most letters relevant to the revision of the NIH Guidelines and 
dated November 30, 1979, or before. (In the November 30 pub- 
lication, reference was made to a 312-page compilation entitled 
"Background Documents on E. col i K-12/P1 Recommendation." It was 
stated that copies could be obtained from the NIH Office of Recom- 
binant DNA Activities [ORDA] and that the material would be 
published in Volume 5 of this series. In consideration of cost, 
however, it has been decided to print only some letters from 
this compilation. The full text is still available from ORDA 
[Building 31, Room 4A52, National Institutes of Health, Bethesda, 
Md. 20205].) An index of all letters in this volume appears at 
the back. 
0 Federal Register of September 13, 1979, containing the final NIH 
Risk Assessment Plan. 
0 Federal Register of November 1, 1979, announcing actions to be 
considered at a meeting of the RAC, December 6-7, 1979. 
0 Minutes of that meeting. 
0 Federal Register of January 17, 1980, promulgating actions recom- 
mended at the meeting. 
0 Copies of 185 letters received by January 18, 1980, commenting on 
the revised Guidelines as proposed on November 30, 1979. (The 
letters are analyzed in the Decision document of January 29, 
1980.) 
The other volumes in this series may be purchased from the Super- 
intendent of Documents, U.S. Government Printing Office, Washington, D.C. 
20402, or viewed in some 600 public libraries of the GP0 depository 
system. The GP0 stock number of Volume 1 is 017-040-00398-6; Volume 2, 
017-040-00422-2 and (supplement: Environmental Impact Statement) 017-040- 
00413-3; Volume 3, 017-040-00429-0 and (appendices) 017-040-00430-3; and 
Volume 4, 017-040-00443-5 and (appendices) 017-040-00442-7. 
TV 
